Domov › Diabetes mellitus 2. typu › Pennsylvania
Klinické štúdie Diabetes mellitus 2. typu v štáte Pennsylvania
30 štúdií pre Diabetes mellitus 2. typu hľadá účastníkov v zariadeniach v štáte Pennsylvania.
Mestá v štáte Pennsylvania
Oficiálny text štúdie (anglicky)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Suburban Research Associates, West Chester
- Cardiology Consultants of Philadelphia Yardley, Yardley
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07783802A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Heritage Valley Medical Group, Beaver
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07564414EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Heritage Valley Medical Group, Beaver
- Capital Area Research, LLC, Camp Hill
- Thomas Jefferson University, Philadelphia
- a 8 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Heritage Valley Medical Group, Beaver
- Preferred Primary Care Physicians-Pittsburgh-63932, Pittsburgh
- Preferred Primary Care Physicians, Pittsburgh
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Capital Area Research, Camp Hill
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 55 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT06112418A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Smithfield
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07776509A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair, Pittsburgh
- Preferred Primary Care Physicians, Uniontown
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Scottdale
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07784270Phenotyping Genetic Risk for Type 2 Diabetes
- Childrens Hospital of Philadelphia, Philadelphia
- University of Pennsylvania, Philadelphia
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 10 až 70 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT04024631A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Philadelphia
- AURORA-2 Clinical Site, Pittsburgh
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- VA Pittsburgh Healthcare System, Pittsburgh
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Frontier Clinical Research, LLC, Scottdale
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT06897475Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Northeast Clinical Research Center, Bethlehem
- Suburban Research Associates, West Chester
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT07271186A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Preferred Primary Care Physicians, Inc., Uniontown
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Feasterville-Trevose
- Research Site, Philadelphia
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Suburban Research Associates, West Chester
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07296484A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Children's Hosptl Philadelphia, Philadelphia
Prebieha náborFáza 3
Vek 10 až 18 · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07282613AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Heritage Valley Medical Group, Beaver
- Capital Area Research LLC, Newport
Prebieha náborFáza 3
Vek 45 a viac · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT07797335A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Children's Hospital of Philadelphia, Philadelphia
- St Christophers Hospital For Children, Philadelphia
Prebieha náborFáza 3
Vek 10 až 17 · Všetky pohlavia · Aktualizované 7. 8. 2026 · NCT06739122The GRoceries Aimed at Increasing Nutrition Study
- University of Pennsylvania, Philadelphia
Prebieha náborUvádza odmenu pre účastníkov
Vek 45 až 70 · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT07167004Pharmacogenetics of Response to GLP1R Agonists
- Amish Research Clinic, Lancaster
Prebieha náborFáza 1Vítaní zdravých dobrovoľníkov
Vek 18 až 89 · Všetky pohlavia · Aktualizované 27. 7. 2026 · NCT05071898CGM for Management of Type 2 Diabetes in Pregnancy
- University of Pennsylvania, Philadelphia
Prebieha nábor
Vek 18 až 50 · Ženy · Aktualizované 29. 6. 2026 · NCT06628453Sleep and Glycemic Control in Type 2 Diabetes Adolescents
- Children's Hospital of Philadelphia, Philadelphia
Prebieha nábor
Vek 12 až 20 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT04213547DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- Children's Hospital of Philadelphia, Philadelphia
Prebieha náborObservačná štúdia
Vek 8 až 15 · Všetky pohlavia · Aktualizované 7. 5. 2026 · NCT06525259Pilot-Testing Strategies to Improve Outcomes for Youth With Type 2 Diabetes by Addressing Health-Related Social Needs
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 13 a viac · Všetky pohlavia · Aktualizované 27. 4. 2026 · NCT07216118Transformative Research in Diabetic Nephropathy 2.0
- Penn Presbyterian Medical Center, Philadelphia
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 3. 2026 · NCT07444203Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes
- Children's Hospital of Pittsburgh, Pittsburgh
Prebieha nábor
Vek 16 až 24 · Všetky pohlavia · Aktualizované 20. 2. 2026 · NCT07270016Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 12 až 17 · Všetky pohlavia · Aktualizované 18. 12. 2025 · NCT05277558CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
- Thomas Jefferson University, Philadelphia
Prebieha nábor
Vek 18 a viac · Ženy · Aktualizované 14. 10. 2025 · NCT07184775Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
- Reading Hospital, an affiliate of Tower Health, West Reading
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 7. 2025 · NCT05893927Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.